These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
427 related items for PubMed ID: 16642480
1. Targeting constitutive and interleukin-6-inducible signal transducers and activators of transcription 3 pathway in head and neck squamous cell carcinoma cells by curcumin (diferuloylmethane). Chakravarti N, Myers JN, Aggarwal BB. Int J Cancer; 2006 Sep 15; 119(6):1268-75. PubMed ID: 16642480 [Abstract] [Full Text] [Related]
2. Curcumin (diferuloylmethane) inhibits constitutive and IL-6-inducible STAT3 phosphorylation in human multiple myeloma cells. Bharti AC, Donato N, Aggarwal BB. J Immunol; 2003 Oct 01; 171(7):3863-71. PubMed ID: 14500688 [Abstract] [Full Text] [Related]
3. (-)-Epigallocatechin gallate induces Fas/CD95-mediated apoptosis through inhibiting constitutive and IL-6-induced JAK/STAT3 signaling in head and neck squamous cell carcinoma cells. Lin HY, Hou SC, Chen SC, Kao MC, Yu CC, Funayama S, Ho CT, Way TD. J Agric Food Chem; 2012 Mar 14; 60(10):2480-9. PubMed ID: 22313388 [Abstract] [Full Text] [Related]
4. Epidermal growth factor receptor-independent constitutive activation of STAT3 in head and neck squamous cell carcinoma is mediated by the autocrine/paracrine stimulation of the interleukin 6/gp130 cytokine system. Sriuranpong V, Park JI, Amornphimoltham P, Patel V, Nelkin BD, Gutkind JS. Cancer Res; 2003 Jun 01; 63(11):2948-56. PubMed ID: 12782602 [Abstract] [Full Text] [Related]
5. Inhibition of JAK2/STAT3 reduces tumor-induced angiogenesis and myeloid-derived suppressor cells in head and neck cancer. Liu JF, Deng WW, Chen L, Li YC, Wu L, Ma SR, Zhang WF, Bu LL, Sun ZJ. Mol Carcinog; 2018 Mar 01; 57(3):429-439. PubMed ID: 29215754 [Abstract] [Full Text] [Related]
6. Constitutive activation of signal transducers and activators of transcription 3 correlates with cyclin D1 overexpression and may provide a novel prognostic marker in head and neck squamous cell carcinoma. Masuda M, Suzui M, Yasumatu R, Nakashima T, Kuratomi Y, Azuma K, Tomita K, Komiyama S, Weinstein IB. Cancer Res; 2002 Jun 15; 62(12):3351-5. PubMed ID: 12067972 [Abstract] [Full Text] [Related]
7. Epigenetic modification of SOCS-1 differentially regulates STAT3 activation in response to interleukin-6 receptor and epidermal growth factor receptor signaling through JAK and/or MEK in head and neck squamous cell carcinomas. Lee TL, Yeh J, Van Waes C, Chen Z. Mol Cancer Ther; 2006 Jan 15; 5(1):8-19. PubMed ID: 16432158 [Abstract] [Full Text] [Related]
10. Honokiol inhibits signal transducer and activator of transcription-3 signaling, proliferation, and survival of hepatocellular carcinoma cells via the protein tyrosine phosphatase SHP-1. Rajendran P, Li F, Shanmugam MK, Vali S, Abbasi T, Kapoor S, Ahn KS, Kumar AP, Sethi G. J Cell Physiol; 2012 May 15; 227(5):2184-95. PubMed ID: 21792937 [Abstract] [Full Text] [Related]
14. Dihydroartemisinin as a Putative STAT3 Inhibitor, Suppresses the Growth of Head and Neck Squamous Cell Carcinoma by Targeting Jak2/STAT3 Signaling. Jia L, Song Q, Zhou C, Li X, Pi L, Ma X, Li H, Lu X, Shen Y. PLoS One; 2016 May 15; 11(1):e0147157. PubMed ID: 26784960 [Abstract] [Full Text] [Related]
15. Guggulsterone (GS) inhibits smokeless tobacco and nicotine-induced NF-κB and STAT3 pathways in head and neck cancer cells. Macha MA, Matta A, Chauhan SS, Siu KW, Ralhan R. Carcinogenesis; 2011 Mar 15; 32(3):368-80. PubMed ID: 21177768 [Abstract] [Full Text] [Related]
16. Suppression of interleukin 6 and 8 production in head and neck cancer cells with curcumin via inhibition of Ikappa beta kinase. Cohen AN, Veena MS, Srivatsan ES, Wang MB. Arch Otolaryngol Head Neck Surg; 2009 Feb 15; 135(2):190-7. PubMed ID: 19221248 [Abstract] [Full Text] [Related]
17. Evidence that TNF-TNFR1-TRADD-TRAF2-RIP-TAK1-IKK pathway mediates constitutive NF-kappaB activation and proliferation in human head and neck squamous cell carcinoma. Jackson-Bernitsas DG, Ichikawa H, Takada Y, Myers JN, Lin XL, Darnay BG, Chaturvedi MM, Aggarwal BB. Oncogene; 2007 Mar 01; 26(10):1385-97. PubMed ID: 16953224 [Abstract] [Full Text] [Related]
18. Evodiamine inhibits STAT3 signaling by inducing phosphatase shatterproof 1 in hepatocellular carcinoma cells. Yang J, Cai X, Lu W, Hu C, Xu X, Yu Q, Cao P. Cancer Lett; 2013 Jan 28; 328(2):243-51. PubMed ID: 23032719 [Abstract] [Full Text] [Related]